Back
HFA Premium Access

Preclinical evaluation of a novel dual acting V1a/V2 vasopressin receptor antagonist by using a noninvasive cardiac output monitor

Session: Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms
Topic: Experimental Heart Failure
Speaker: Doctor T. Mondritzki (Wuppertal, DE)
Event: Heart Failure 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Thomas Mondritzki

Bayer AG, Wuppertal (Germany)
0 follower

46 more presentations in this session

Increased expression of galectin-3 in the interstitium of left ventricular myocardium of dogs with chronic heart failure

Speaker: Professor H. Sabbah (Detroit, US)

Access
Abstract
Slides
Like
Thumbnail

Necroptosis in post-ischemic heart failure: causality of cardiac dysfunction and remodeling?

Speaker: Mr M. Lichy (Bratislava, SK)

Access
Abstract
Like
Thumbnail

Genetic diagnosis in transthyretin cardiac amyloidosis - a single Polish centre experience

Speaker: Doctor M. Gawor (Warsaw, PL)

Access
Abstract
Like
Thumbnail

Differential endomyocardial expression of SGLT1 in idiopathic dilated cardiomyopathy patients with and without diabetes mellitus.

Speaker: Doctor M. Vanderheyden (Aalst, BE)

Access
Abstract
Like
Thumbnail

Decreased longitudinal left ventricular contraction after acute myocardial infarction in a porcine model revealing the opportunity for new treatments with mechanical circulatory support devices

Speaker: Mr J. Berg (Lund, SE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Doctor T. Mondritzki, Professor H. Sabbah, Mr M. Lichy, Doctor M. Gawor, Doctor M. Vanderheyden...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources